Jim Simons
TNGX icon

Jim Simons’s Tango Therapeutics TNGX Stock Holding History

Jim Simons’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.4M Buy
+748,300
New +$18.5M 0.03% 637
2025
Q4 		– Sell
-55,300
Closed -$465K – 3764
2025
Q3 		$465K Sell
55,300
-10,200
-16% -$69K ﹤0.01% 2828
2025
Q2 		$335K Sell
65,500
-109,000
-62% -$270K ﹤0.01% 3003
2025
Q1 		$239K Buy
174,500
+153,000
+712% +$376K ﹤0.01% 3011
2024
Q4 		$66.4K Buy
+21,500
New +$100K ﹤0.01% 3348
2024
Q2 		– Sell
-65,600
Closed -$521K – 3961
2024
Q1 		$521K Sell
65,600
-55,400
-46% -$594K ﹤0.01% 2846
2023
Q4 		$1.2M Buy
121,000
+82,800
+217% +$719K ﹤0.01% 2282
2023
Q3 		$430K Sell
38,200
-40,500
-51% -$247K ﹤0.01% 2781
2023
Q2 		$261K Buy
78,700
+17,800
+29% +$64K ﹤0.01% 3189
2023
Q1 		$241K Buy
60,900
+35,600
+141% +$207K ﹤0.01% 3203
2022
Q4 		$183K Buy
25,300
+14,100
+126% +$99.2K ﹤0.01% 3448
2022
Q3 		$41K Buy
+11,200
New +$47.8K ﹤0.01% 3802

Other funds holding TNGX

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Boxer Capital Management
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jim Simons's TNGX Position: Q2 2026 in Review

Jim Simons opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 748,300 shares worth $23.4M. The stake represents 0.03% of the portfolio and ranks #637 among its holdings. This is a return to the name: Jim Simons previously reported a position in TNGX as recently as Q3 2025.

Jim Simons first reported a position in TNGX in Q3 2022 and has held it in 12 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Jim Simons held 748,300 shares of Tango Therapeutics worth $23.4M as of Q2 2026.
  • Tango Therapeutics was a new Jim Simons position in Q2 2026.
  • Tango Therapeutics made up 0.03% of Jim Simons's portfolio in Q2 2026, its #637 holding.
  • Jim Simons first reported a position in Tango Therapeutics in Q3 2022 and has held it in 12 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.